113 related articles for article (PubMed ID: 29446)
1. Brain receptors for dopamine and neuroleptics.
Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D
Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446
[No Abstract] [Full Text] [Related]
2. Dopamine receptors, neuroleptics, and schizophrenia.
Snyder SH
Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
[TBL] [Abstract][Full Text] [Related]
3. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
4. Hallucinogen binding to dopamine/neuroleptic receptors.
Whitaker PM; Seeman P
J Pharm Pharmacol; 1977 Aug; 29(8):506-7. PubMed ID: 19605
[No Abstract] [Full Text] [Related]
5. Dopamine receptors in the central nervous system.
Seeman P; Tedesco JL; Lee T; Chau-Wong M; Muller P; Bowles J; Whitaker PM; McManus C; Tittler M; Weinreich P; Friend WC; Brown GM
Fed Proc; 1978 Feb; 37(2):131-6. PubMed ID: 414936
[TBL] [Abstract][Full Text] [Related]
6. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
Oelssner W; Peinhardt G; Büge A
Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
[TBL] [Abstract][Full Text] [Related]
7. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
Spano PF; Memo M; Govoni S; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
[No Abstract] [Full Text] [Related]
8. Neuroleptic/dopamine receptors: elevation and reversal.
List S; Seeman P
Adv Biochem Psychopharmacol; 1980; 24():95-101. PubMed ID: 6105811
[No Abstract] [Full Text] [Related]
9. Radiopharmaceuticals for receptor imaging.
Tewson TJ
J Nucl Med; 1983 May; 24(5):442-3. PubMed ID: 6302240
[No Abstract] [Full Text] [Related]
10. The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.
Creese I; Burt DR; Synder SH
Life Sci; 1975 Dec; 17(11):1715-9. PubMed ID: 1207384
[No Abstract] [Full Text] [Related]
11. 3H-Apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment.
Leysen JE
Adv Biochem Psychopharmacol; 1980; 24():123-32. PubMed ID: 6105770
[No Abstract] [Full Text] [Related]
12. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
Marshall AM; Mishra RK
Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
[No Abstract] [Full Text] [Related]
13. Central nervous system dopamine receptors.
Creese I
Adv Biochem Psychopharmacol; 1980; 21():235-42. PubMed ID: 6103649
[No Abstract] [Full Text] [Related]
14. Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.
Burt DR; Creese I; Snyder SH
Mol Pharmacol; 1976 Jul; 12(4):631-8. PubMed ID: 958211
[No Abstract] [Full Text] [Related]
15. Binding of [3H]-neuroleptics to dopamine receptors on rat cerebral membranes [proceedings].
Howlett DR; Nahorski SR
Br J Pharmacol; 1978 Mar; 62(3):396P. PubMed ID: 25103
[No Abstract] [Full Text] [Related]
16. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
Enna SJ; Bennett JP; Burt DR; Creese I; Snyder SH
Nature; 1976 Sep; 263(5575):338-41. PubMed ID: 8733
[No Abstract] [Full Text] [Related]
17. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Lideman RR; Zlobina GP; Mukhin AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
[No Abstract] [Full Text] [Related]
18. 3H-Apomorphine interactions with dopamine receptors in calf brain.
Thal L; Creese I; Snyder SH
Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
[TBL] [Abstract][Full Text] [Related]
19. [Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
Havemann U
Arzneimittelforschung; 1981; Suppl 27():18-22. PubMed ID: 6118158
[No Abstract] [Full Text] [Related]
20. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.
Richelson E
J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
